Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Total Long Term Debt (2020 - 2023)

Historic Total Long Term Debt for MDxHealth (MDXH) over the last 4 years, with Q4 2023 value amounting to $39.1 million.

  • MDxHealth's Total Long Term Debt rose 299.17% to $39.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was $39.1 million, marking a year-over-year increase of 299.17%. This contributed to the annual value of $39.1 million for FY2023, which is 299.17% up from last year.
  • Latest data reveals that MDxHealth reported Total Long Term Debt of $39.1 million as of Q4 2023, which was up 299.17% from $38.0 million recorded in Q4 2022.
  • MDxHealth's Total Long Term Debt's 5-year high stood at $39.1 million during Q4 2023, with a 5-year trough of $10.3 million in Q4 2021.
  • Moreover, its 4-year median value for Total Long Term Debt was $25.2 million (2020), whereas its average is $24.9 million.
  • Its Total Long Term Debt has fluctuated over the past 5 years, first tumbled by 1643.62% in 2021, then surged by 26987.83% in 2022.
  • Over the past 4 years, MDxHealth's Total Long Term Debt (Quarter) stood at $12.3 million in 2020, then fell by 16.44% to $10.3 million in 2021, then skyrocketed by 269.88% to $38.0 million in 2022, then increased by 2.99% to $39.1 million in 2023.
  • Its last three reported values are $39.1 million in Q4 2023, $38.0 million for Q4 2022, and $10.3 million during Q4 2021.